Testing services · Panels

All targets, by organism

Every organism detected across InnovexLab’s panels, once, with the panels it appears on.

General medical information for education only, not medical advice. Targets as listed on InnovexLab’s requisition forms. Detection of a target does not by itself establish infection or determine treatment; results are interpreted by the ordering clinician with the clinical picture and, where indicated, culture and susceptibility testing.

Organisms and panels

Panels: UTI · Wound · Respiratory · Gastrointestinal (GI) · STI · Women's health · Nail fungal · Eye infection · Resistance genes

Bacteria: Gram-negative (29)

OrganismPanels
Acinetobacter baumannii
Bacteroides fragilis
Bordetella species
Bordetella pertussis; Bordetella parapertussis; Bordetella holmesii
Campylobacter
Campylobacter jejuni; Campylobacter coli; Campylobacter spp.
Citrobacter freundii
Coxiella burnetii
Diarrheagenic Escherichia coli
Shiga toxin-producing E. coli (STEC) including O157; enteroaggregative (EAEC); enteroinvasive (EIEC); enteropathogenic (EPEC); enterotoxigenic (ETEC)
Enterobacter cloacae complex
Escherichia coli
E. coli
Haemophilus ducreyi
Haemophilus influenzae
including H. influenzae type b (Hib)
Helicobacter pylori
Kingella kingae
Klebsiella aerogenes
formerly Enterobacter aerogenes
Klebsiella oxytoca
Klebsiella pneumoniae
Legionella species
Legionella pneumophila; Legionella longbeachae
Moraxella catarrhalis
Morganella morganii
Neisseria gonorrhoeae
Plesiomonas shigelloides
Proteus mirabilis and Proteus vulgaris
Proteus mirabilis; Proteus vulgaris
Providencia stuartii
Pseudomonas aeruginosa
Salmonella
Salmonella spp.
Serratia marcescens
Shigella
Shigella spp.
Vibrio species
Vibrio cholerae; Vibrio parahaemolyticus; Vibrio vulnificus
Yersinia enterocolitica

Bacteria: Gram-positive (11)

Bacteria: atypical and cell-wall-deficient (7)

Vaginal microbiome bacteria (3)

OrganismPanels
Atopobium vaginae, BVAB2 and Megasphaera
Atopobium vaginae (Fannyhessea vaginae); BV-associated bacterium 2 (BVAB2); Megasphaera type 1; Megasphaera type 2
Gardnerella vaginalis
Lactobacillus species
Lactobacillus crispatus; Lactobacillus jensenii; Lactobacillus iners

Viruses: respiratory (12)

OrganismPanels
Adenovirus
Adenovirus (respiratory and gastrointestinal panels)
Enteroviruses
Enterovirus (respiratory panel); Enterovirus PAN (gastrointestinal panel)
Human bocavirus
Human metapneumovirus
Metapneumovirus A and B
Human parainfluenza viruses
Parainfluenza virus 1; 2; 3; 4
Human parechovirus
Parechovirus (respiratory panel); Human parechovirus (gastrointestinal panel)
Influenza viruses
Influenza A (including subtypes H1N1-2009 and H3); Influenza B; Influenza C
Respiratory syncytial virus (RSV)
RSV A; RSV B
Rhinovirus
SARS-CoV and MERS-CoV
SARS (SARS-CoV-1); MERS (Middle East respiratory syndrome coronavirus)
SARS-CoV-2 (COVID-19)
Seasonal human coronaviruses
Coronavirus 229E; Coronavirus HKU1; Coronavirus NL63; Coronavirus OC43

Viruses: gastrointestinal (4)

Viruses: skin, eye and genital (3)

Fungi: yeasts (3)

OrganismPanels
Candida albicans
Candida auris
Other Candida species
Candida glabrata (Nakaseomyces glabratus); Candida krusei (Pichia kudriavzevii); Candida parapsilosis; Candida tropicalis; Candida lusitaniae (Clavispora lusitaniae)

Fungi: molds and dermatophytes (5)

OrganismPanels
Alternaria, Acremonium and Neofusicoccum
Alternaria alternata; Acremonium strictum; Neofusicoccum mangiferae
Aspergillus terreus and Aspergillus niger
Aspergillus terreus; Aspergillus niger
Dermatophytes
Trichophyton spp. (including T. rubrum); Trichophyton interdigitale; Epidermophyton floccosum; Microsporum audouinii; Microsporum canis
Fusarium solani
Pneumocystis jirovecii

Parasites (6)

Medical disclaimer

This page is general educational information summarized from published public-health and professional-society guidance. It is not medical advice, a diagnosis or a treatment recommendation, and reading it does not create a clinician–patient relationship with InnovexLab. Decisions about testing, diagnosis and treatment belong to the treating clinician, using the patient’s history and examination, laboratory and susceptibility results, local resistance patterns and current guidelines. Guidance changes over time; consult the original sources for the latest version. InnovexLab provides this information as is and does not warrant that it is complete or current.

Patients with questions about their health should contact their own healthcare provider. In an emergency, call 911.

Sources, image credits and editorial policy

Discuss a testing program with InnovexLab

Review the panel that fits your patients, its specimen requirements, and how results and billing work.